Asabys Partners
Investor profile
Venture capital
Asabys Partners has backed 15 European tech companies across 19 funding rounds between 2019 and 2026, joining rounds totalling €734M. Most active in Healthtech. Data as of 4 Nov 2026.
Also recorded as: Asabys
Deals
19
distinct rounds
Companies
15
backed
Active span
2019–2026
8 yrs
Total round €
€734M
sum of rounds joined
Deals by year
distinct rounds / yearAsabys Partners — deals by year — interactive chart.
Data table
| Asabys Partners — deals by year | |
|---|---|
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 4 |
Top sectors
by dealsAsabys Partners — top sectors — interactive chart.
Data table
| Asabys Partners — top sectors | |
|---|---|
| Healthtech | 19 |
Stages
by dealsAsabys Partners — stages — interactive chart.
Data table
| Asabys Partners — stages | |
|---|---|
| Series A | 6 |
| Series B | 5 |
| Other | 3 |
| Seed | 2 |
| Series C | 2 |
| Series D+ | 1 |
Countries
by dealsAsabys Partners — countries — interactive chart.
Data table
| Asabys Partners — countries | |
|---|---|
| Spain | 13 |
| France | 2 |
| Iceland | 2 |
| Belgium | 1 |
| Germany | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Ysios Capital4
- CDTI3
- Aliath Bioventures2
- Amadeus Capital Partners2
- APEX Ventures2
- Columbus Venture Partners2
- Gilde Healthcare2
- Institut Català de Finances (ICF)2
- Mérieux Equity Partners2
- New Enterprise Associates2
- Novartis Venture Fund2
- Sanofi Ventures2
- Sofinnova Partners2
- UCB Ventures2
- Wellington Partners2
- Adara Ventures1
- Alta Life Sciences1
- Avançsa1
- Axis-Ico1
- Bpifrance1
- Buenavista Equity Partners1
- Build Collective1
- CDTI Innvierte1
- CGHealth Ventures1
- Co-Investment Fund (FOCO)1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| SpliceBio | Spain | 2 | €168M |
| Agomab Therapeutics | Belgium | 1 | €83M |
| Ona Therapeutics | Spain | 1 | €74M |
| Anaconda Biomed | Spain | 2 | €69M |
| Sidekick Health | Iceland | 2 | €69M |
| Inbrain Neuroelectronics | Spain | 2 | €61M |
| Deepull | Spain | 1 | €50M |
| Quibim | Spain | 1 | €50M |
| Qida | Spain | 1 | €37M |
| Medlumics | Spain | 1 | €18M |
| iPremom | Spain | 1 | €15M |
| Gradient Denervation Technologies | France | 1 | €14M |
| SafeHeal | France | 1 | €10M |
| ALLOX | Spain | 1 | €9.4M |
| Cara Care | Germany | 1 | €6.2M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| SpliceBio | Series B | €118M | 2025-06 |
| Agomab Therapeutics | Series D+ | €83M | 2024-10 |
| Ona Therapeutics | Series B | €74M | 2026-06 |
| Sidekick Health | Series B | €52M | 2022-05 |
| SpliceBio | Series A | €50M | 2022-02 |
| Deepull | Series C | €50M | 2025-04 |
| Quibim | Series A | €50M | 2025-01 |
| Inbrain Neuroelectronics | Series B | €46M | 2024-10 |
| Qida | Other | €37M | 2025-11 |
| Anaconda Biomed | Series B | €20M | 2019-10 |